RE:RE:End of year share priceIn terms of real value CZO could arguably be seen as worth $1.25 right now.
What's the value of AEZS's
C$50 million cash, C$113 million in tax loss carryforwards, a diagnostic cashcow about to be partnered with its most important market potentially approved in 2024, and pipeline of other assets(eg. AIM Biologicals)? That should be worth at least C$100 million, in my opinion. AEZS wouldn't agree to a merger of equals if it didn't see CZO's real value at about C$100 million. A C$100 million value with 80 million CZO shares is $1.25 per share. If the deal is completed and the expected diagnostic test deal and PGX deal are announced that value could be realized; exspecially if the biotech market has legs. The company also has a number of other events ahead.
Apostata wrote: Here's a blast from the past. Anyone remember August?
Apostata wrote: Since we're all stuck here in limbo, I thought I'd see whether anyone would like to guess where the share price will be at the end of the last trading day of 2023.
I'm going to say .54
Any takers?
This company has become a joke.